NATALIE TAYLOR: Open Payments
NPI 1679120711 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 10 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $264 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 1 | $160 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| BSN Medical Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
| Corium, LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: RUBY Coil, REXULTI, JOBST SPORT, BOTOX, MOUNJARO, QULIPTA, OTEZLA, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
